About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting ...
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
Mitsubishi Chemical Group Corp. (MCG; Tokyo) announced that it has decided to transfer its consolidated subsidiary Mitsubishi Tanabe Pharma Corp. (MTPC; ...
Bain's latest acquisition follows a string of hefty investments the private equity firm has made in Japan in recent months.
Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...
Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback